Performance

BIOA -21.63%

Watchlist

Select an item

RETURNS	1D	YTD	1Y	5Y Ann.	Max DD	Sharpe	Div. Yield
BIOA	+6.55%	-56.99%	-21.63%	—	-80.72%	0.41	0.00%

Summary

BIOA at a glance

BIOA returned -21.63% over the past year. Its worst drop in that year was -80.72%, smaller than 1% of stocks on Redstone, and its Sharpe ratio of 0.41 beats 46% of stocks on Redstone. It pays no dividends.

Ranking

How BIOA ranks

Current Drawdown

-77.33%

Rolling Volatility

89.14%

Actions

Metrics

Risk Indicators

Alpha25.63%

Beta1.82x

Sharpe0.41

Sortino0.55

Omega1.09

Calmar-0.27

Martin1.11

Profile

About BIOA

Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging.

Sector: Health Care
Industry: Pharmaceutical Preparations
Market cap: $261M
Listed: Sep 2024
Employees: 62
Headquarters: Emeryville, CA
Website: bioagelabs.com

Comparisons

BIOA: BioAge Labs, Inc.

BIOA at a glance

How BIOA ranks

Current Drawdown

Rolling Volatility

About BIOA

Related comparisons